Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

61.10p
   
  • Change Today:
    -0.90p
  • 52 Week High: 119.60p
  • 52 Week Low: 35.30p
  • Currency: UK Pounds
  • Shares Issued: 540.14m
  • Volume: 903,763
  • Market Cap: £330.03m
  • RiskGrade: 119

Broker List

Order by
Date Broker name New Price Old price target New price target Broker change
25-May-23 Berenberg Bank Buy 62.30p - 105.00p Reiteration
25-May-23 Numis Buy 62.30p - 105.00p Reiteration
17-Mar-23 Peel Hunt Limited Hold 62.10p - 65.00p New Coverage
08-Aug-22 RBC Capital Markets Outperform 94.70p 130.00p 130.00p Reiteration
13-Sep-17 Investec Securities Buy 52.75p - 59.00p New Coverage
13-Sep-17 N 1 Singer Not Rated 52.75p - - Reiteration
18-Jul-17 Numis Securities Buy 52.50p - 60.00p Reiteration
09-May-17 FinnCap Buy 49.00p - 65.00p Reiteration
13-Jul-15 Canaccord Genuity Hold 45.00p 40.00p 40.00p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 61.10p
Change Today -0.90p
% Change -1.45 %
52 Week High 119.60p
52 Week Low 35.30p
Volume 903,763
Shares Issued 540.14m
Market Cap £330.03m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
40.75% above the market average40.75% above the market average40.75% above the market average40.75% above the market average40.75% above the market average
73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average
Price Trend
14.78% below the market average14.78% below the market average14.78% below the market average14.78% below the market average14.78% below the market average
8.20% above the sector average8.20% above the sector average8.20% above the sector average8.20% above the sector average8.20% above the sector average
Income
27.8% below the market average27.8% below the market average27.8% below the market average27.8% below the market average27.8% below the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
Growth
90.46% below the market average90.46% below the market average90.46% below the market average90.46% below the market average90.46% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 4
Buy 1
Neutral 2
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 02-Jun-2023

Time Volume / Share Price
09:58 193,439 @ 62.00p
16:39 50,000 @ 61.39p
16:38 49,453 @ 61.39p
16:38 25,000 @ 61.10p
16:35 3,321 @ 61.10p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Jo Le Couilliard

Top of Page